Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection
Michael J. Peluso, Dylan Ryder, Robert R. Flavell, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 754
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Long COVID science, research and policy
Ziyad Al‐Aly, Hannah Davis, Lisa McCorkell, et al.
Nature Medicine (2024) Vol. 30, Iss. 8, pp. 2148-2164
Open Access | Times Cited: 106
Mechanisms of long COVID and the path toward therapeutics
Michael J. Peluso, Steven G. Deeks
Cell (2024)
Open Access | Times Cited: 33
Early biological markers of post-acute sequelae of SARS-CoV-2 infection
Scott Lu, Michael J. Peluso, David V. Glidden, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study
Zoe Swank, Ella Borberg, Yulu Chen, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 12, pp. 1599-1605
Closed Access | Times Cited: 11
Targeting the SARS-CoV-2 reservoir in long COVID
Amy D. Proal, Soo Aleman, Morgane Bomsel, et al.
The Lancet Infectious Diseases (2025)
Closed Access | Times Cited: 1
Post-COVID-19 condition in prospective inpatient and outpatient cohorts
Antti Hurme, Arja Viinanen, Johanna Teräsjärvi, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Rates of infection with other pathogens after a positive COVID-19 test versus a negative test in US veterans (November, 2021, to December, 2023): a retrospective cohort study
Miao Cai, Evan Xu, Yan Xie, et al.
The Lancet Infectious Diseases (2025)
Closed Access | Times Cited: 1
Translating insights into therapies for Long Covid
Annukka A.R. Antar, Andrea L. Cox
Science Translational Medicine (2024) Vol. 16, Iss. 773
Open Access | Times Cited: 4
Animal Models of Non-Respiratory, Post-Acute Sequelae of COVID-19
Abigail Vanderheiden, Michael Diamond
Viruses (2025) Vol. 17, Iss. 1, pp. 98-98
Open Access
Cells that survive acute SARS-CoV-2 infection contribute to inflammation and lung regeneration in mice
Ruangang Pan, David K. Meyerholz, Stanley Perlman
mBio (2025)
Open Access
COVID-19 clinical presentation, management, and epidemiology: a concise compendium
David P. Maison, Hawi Tasissa, Amelia N. Deitchman, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Serum Spike Protein Persistence Post COVID Is Not Associated with ME/CFS
Annick Fehrer, Franziska Sotzny, Laura Kim, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1086-1086
Open Access
Immunological and clinical markers of post-acute sequelae of COVID-19: Insights from mild and severe cases six months post-infection
William Mouton, Sophia Djebali, Marine Villard, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Discordant Outcomes of SARS-CoV-2 Infection in Household Contacts
Ye‐Ji Lee, Alison Tarke, Tertuliano Alves Pereira Neto, et al.
(2025)
Closed Access
Emerging PET radiotracers for vascular imaging
Marta Peverelli, Jason M. Tarkin
Lara D. Veeken (2025) Vol. 64, Iss. Supplement_1, pp. i33-i37
Closed Access
Activity of the apoptosis-inducing ligand TRAIL in the blood of patients with chronic obstructive pulmonary disease who had COVID-19
Екатерина Кулик, Валентина Павленко, Светлана Нарышкина
Bulletin physiology and pathology of respiration (2025), Iss. 95, pp. 18-25
Closed Access
Lower Expression of SARS-CoV-2 Host Cell Entry Genes in the Intestinal Mucosa of IBD Patients With Quiescent or Mildly Active Disease
Laura Francesca Pisani, Guglielmo Albertini Petroni, Gabriela A. N. Crespi, et al.
Inflammatory Bowel Diseases (2025)
Closed Access
SARS-CoV-2 antivirals and post-COVID-19 condition
Ziyad Al‐Aly
The Lancet Infectious Diseases (2024)
Closed Access | Times Cited: 3
More than “Brain Fog”: Cognitive Dysfunction and the Role of Occupational Therapy in Long COVID
Helen Skiffington, Ciara Breen
Cardiopulmonary Physical Therapy Journal (2024) Vol. 36, Iss. 1, pp. 39-49
Closed Access | Times Cited: 2
Long COVID Is Not a Functional Neurologic Disorder
Todd E. Davenport, Svetlana Blitshteyn, Nicola Clague-Baker, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 8, pp. 799-799
Open Access | Times Cited: 1
Unmasking the hidden impact of viruses on tuberculosis risk
Fatoumatta Darboe, Josephine F. Reijneveld, David P. Maison, et al.
Trends in Immunology (2024) Vol. 45, Iss. 9, pp. 649-661
Open Access | Times Cited: 1
[18F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non–Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy
Jelena Levi, Millie Das, Minal Vasanawala, et al.
Journal of Nuclear Medicine (2024), pp. jnumed.124.268253-jnumed.124.268253
Closed Access | Times Cited: 1
Long Coronavirus Disease and the Brain
Éric Guedj, Alexandre Cionca, Julie Péron, et al.
PET Clinics (2024)
Closed Access | Times Cited: 1
Infection-associated chronic conditions: Why Long Covid is our best chance to untangle Osler’s web
Michael J. Peluso, Maureen R. Hanson, Steven G. Deeks
Science Translational Medicine (2024) Vol. 16, Iss. 773
Open Access | Times Cited: 1
The consequences of SARS-CoV-2 within-host persistence
Alex Sigal, Richard A. Neher, Richard Lessells
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top